IDiyas

For the Inventor, By the Inventor

Hyogo, Japan

Tsutomu Sugasawa

USPTO Granted Patents = 11

Average Co-Inventor Count = 2.4

ph-index = 4

Forward Citations = 81(Granted Patents)


Location History:

  • Kobe, JA (1977)
  • Kobe, JP (1979 - 1985)
  • Hyogo, JP (1985 - 1992)

Company Filing History:

goldMedal11 out of 1,001 
 
Shionogi Company Limited
 patents

Years Active: 1977-1992

Loading Chart...
11 patents (USPTO):Explore Patents
1. 5155026 - Method for determination of nagase and reagent therefor (1992-10-13),
2. 4857645 - Process for introducing a thiocarboxylic ester group at the (1989-08-15),
3. 4831132 - Ortho-mono-substituted amino)phenylimines (1989-05-16),
4. 4774331 - Process for ortho-cyanation of phenols or phenylamines (1988-09-27),
5. 4579685 - Process for preparing 1-substituted-1,4-benzodiazepine derivatives (1986-04-01),
6. 4560684 - 1,4-Benzodiazepine derivatives (1985-12-24),
7. 4551554 - Process for production of 2-haloacetylphenols (1985-11-05),
8. 4410730 - Process for the production of o-(N-monosubstituted amino)benzyl alcohols (1983-10-18),
9. 4186144 - Process for the production of cyanopinacolone (1980-01-29),
10. 4160784 - Process for the production of o-aminophenyl ketone derivatives (1979-07-10),
11. 4031098 - Camptothecin analogues (1977-06-21),

Title: The Innovative Mind of Tsutomu Sugasawa

Introduction

Tsutomu Sugasawa, an accomplished inventor based in Hyogo, Japan, has made significant contributions to the field of chemical innovations. With a remarkable portfolio of 11 patents, he has demonstrated a dedication to advancing technology through his inventive spirit. Sugasawa's work primarily focuses on the synthesis of compounds essential for various industrial applications.

Latest Patents

Two of Tsutomu Sugasawa’s latest patents exemplify his innovative endeavors. The first patent is a method for the determination of N-acetyl-.beta.-D-glucosaminidase (NAGase) activity, which includes a highly sensitive reagent that allows for the colorimetric determination of renal dysfunction. This method utilizes sodio-3,3'-dichlorophenolsulfonphthaleinyl N-acetyl-.beta.-D-glucosaminide and a buffer, ensuring precise, quick, and easy diagnoses.

The second patent involves a process for introducing a thiocarboxylic ester group at the ortho-position of phenols or phenylamines. This innovative technique facilitates the synthesis of important compounds, including medicinals, pesticides, and dyes, by reacting phenyl compounds with various thiocyanates in the presence of a boron trihalide.

Career Highlights

Tsutomu Sugasawa is currently employed at Shionogi & Company Limited, where his research efforts contribute significantly to the company's reputation for excellence in pharmaceuticals and biochemistry. His inventive mindset has positioned him as a key player in developing new technologies and methodologies within the organization.

Collaborations

Throughout his career, Sugasawa has enjoyed collaborative relationships with esteemed colleagues such as Kazuyuki Sasakura and Makoto Adachi. These partnerships have allowed for the sharing of ideas and expertise, further enriching the innovative environment at Shionogi & Company Limited.

Conclusion

Tsutomu Sugasawa stands out as an influential figure in the realm of innovations, holding a substantial number of patents that showcase his dedication to solving complex scientific challenges. His work not only advances technology in the chemical industry but also enhances the quality of life through the development of medical diagnostics and therapeutics. As he continues to innovate, Sugasawa's contributions are certain to leave a lasting impact in his field.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…